CoChat

A hollow fiber membrane-based liver organoid-on-a-chip model for examining drug metabolism and transport

Open access
Myszczyszyn, Adam, Muench, Anna, Lehmann, Vivian, Sinnige, Theo, van Steenbeek, Frank G, Bouwmeester, Manon, Samsom, Roos-Anne, Keuper-Navis, Marit, van der Made, Thomas K, Kogan, Daniel, Braem, Sarah, van der Laan, Luc J W, Eslami Amirabadi, Hossein, van de Steeg, Evita, Masereeuw, Rosalinde, Spee, Bart · 2025 · Biofabrication

Published version of a preprint

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Abstract

Liver-on-a-chip models predictive for both metabolism, and blood and canalicular transport of drug candidates in humans are lacking. Here, we established a bioengineered and 3Rs-complied (animal component-free) hepatocyte-like millifluidic system based on 3D hollow fiber membranes (HFMs), recombinant human laminin 332 coating and adult human stem cell-derived organoids. Organoid fragments formed polarized and tight monolayers on HFMs with improved hepatocyte-like maturation, as compared to standard 3D organoid cultures in Matrigel from matched donors. Gene expression profiling and immunofluorescence revealed that hepatocyte-like monolayers expressed a broad panel of phase I (e.g. CYP3A4, CYP2D6, CYP2C9) and II (e.g. UGTs, SULTs) drug-metabolizing enzymes and drug transporters (e.g. MDR1, MRP3, OATP1B3). Moreover, statically cultured monolayers displayed phase I and II metabolism of a cocktail of six relevant compounds, including midazolam and 7-hydroxycoumarin. We also demonstrated the disposition of midazolam in the basal/blood-like circulation and apical/canalicular-like compartment of the millifluidic chip. Finally, we studied the bioavailability of midazolam and coumarin on-a-chip in combination with a small intestine-like system. In conclusion, we generated a proof-of-concept liver organoid-on-a-chip model for examining metabolism and transport of drugs, which can be further developed to predict pharmacokinetics’ (PK)/absorption, distribution, metabolism and excretion (ADME) profiles in humans.

Overview

Integrity signals

Registry

Crossref · 10.1088/1758-5090/adc3ce

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 88 references

Cited by

See all 17

Metadata

Authors
Myszczyszyn, A., Muench, A., Lehmann, V., Sinnige, T., van Steenbeek, F. G., Bouwmeester, M., Samsom, R.-A., Keuper-Navis, M., van der Made, T. K., Kogan, D., Braem, S., van der Laan, L. J. W., Eslami Amirabadi, H., van de Steeg, E., Masereeuw, R., & Spee, B.
Affiliations
  • Utrecht University (NL)
  • Netherlands Organisation for Applied Scientific Research (NL)
Venue
Biofabrication
Published
2025-04-01
Volume
17
Issue
2
Pages
025035
ISSN
  • 1758-5082 (ISSN-L)
  • 1758-5090
OpenAlex
W4408701756
Cited by
14
References
88
Citations by year
2026: 9 · 2025: 5
FWCI
3.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Biofabrication (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • TNO Repository (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
Funders
Health~Holland (LSHM20045-SGF)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
liver organoids, hollow fiber membranes, organ-on-a-chip, drug metabolism, drug transport, stem cell-derived organoids, midazolam, umbelliferone, drug-metabolizing enzymes, drug transporters, canalicular transport, bioavailability, ADME prediction
MeSH terms
Biological Transport, Pharmaceutical Preparations, Humans, Liver, Membranes, Artificial, Midazolam, Models, Biological, Organoids, Hepatocytes, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.